Interstitial Lung Disease in Patients With Systemic Sclerosi…
Established
24
Citations113
Refs2020
Year
Search Works
Work Details
- DOI 10.3389/fimmu.2020.01990
- PMID https://pubmed.ncbi.nlm.nih.gov/33013852
- OpenAlex ID W3083476619
- Type Article
- Language EN
- Published 04 Sep 2020
- Volume 11
- Pages 1990
- Source Frontiers in Immunology
- Publisher Frontiers Media
- FWCI 1.26
- Countries 1
- Institutions 1
- Added 10 Oct 2025
- Updated 23 Oct 2026
External Links
MENU
0
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
Article 2020 EN Gold
Systemic sclerosis (SSc) is an autoimmune connective tissue disease, characterized by immune dysregulation and progressive fibrosis. Interstitial lung disease (ILD) is the most common cause of death among SSc patients and there are currently very limited approved disease-modifying treatment options for systemic sclerosis-related interstitial lung disease (SSc-ILD). The mechanisms underlying pulmon…
24
Citations
113
References
5
Authors
1.26
FWCI
Citations by Year
Last 6 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
5 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Padmini P. S. J. Khedoe Corresponding | Leiden University Medical Cent… (NL) | |
| 2 | Emiel R. Marges | Leiden University Medical Cent… (NL) | |
| 3 | Pieter Sicco Hiemstra | Leiden University Medical Cent… (NL) | |
| 4 | Maarten K. Ninaber | Leiden University Medical Cent… (NL) | |
| 5 | Miranda Geelhoed | Leiden University Medical Cent… (NL) | — |
Related Works
10Data: OpenAlex